• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RESPIRONICS INC DREAMSTATION CPAP PRO; VENTILATOR, NON-CONTINUOUS (RESPIRATOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RESPIRONICS INC DREAMSTATION CPAP PRO; VENTILATOR, NON-CONTINUOUS (RESPIRATOR) Back to Search Results
Model Number CAX400H12C
Medical Device Problem Codes Contamination (1120); Degraded (1153)
Health Effect - Clinical Codes Chest Pain (1776); Dyspnea (1816); Headache (1880); Inflammation (1932); Dizziness (2194); Sore Throat (2396); Respiratory Tract Infection (2420); Unspecified Respiratory Problem (4464); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/14/2021
Type of Reportable Event Malfunction
Event or Problem Description
The manufacturer received information alleging an issue related to a continuous positive airway pressure (cpap) device's sound abatement foam.There was no report of patient harm or injury.The manufacturer's investigation is ongoing.A follow-up report will be submitted when the manufacturer's investigation is complete.
 
Additional Manufacturer Narrative
The manufacturer previously reported an allegation of an issue related to sound abatement foam.This action was reported to fda per 21 cfr part 806.The device will be corrected per res 88058.
 
Additional Manufacturer Narrative
The manufacturer previously received information alleging an issue related to a continuous positive airway pressure (cpap) device's sound abatement foam.There was no report of patient harm or injury.In the initial report, section b5 was not updated, the correct b5 should be- the patient has alleged headaches, sore throat, dizziness, lightheaded, shortness of breath, nasal soreness, and chest pain.There was no report of serious or permanent patient harm or injury.The device was returned to the manufacturer's product investigation laboratory for investigation.An external and internal visual inspection of device was completed by the manufacturer and found evidence of dark dust contaminant on the top enclosure, front panel, rear enclosure, and bottom enclosure, unknown dust contaminant on the blower, blower seal, and blower box, keratin-like substance on the blower box outlet, liquid ingress on the blower and blower box.The manufacturer found no evidence of sound abatement foam degradation.The device's downloaded event log was reviewed by the manufacturer and found no error logged.The device was applied power and the device operated properly.The manufacturer concludes the contaminates found were consistent with dark dust contaminant on the top enclosure, front panel, rear enclosure, and bottom enclosure, keratin-like substance on the blower box outlet, liquid ingress on the blower and blower box and an unknown dust contaminant on the blower was inconsistent with the sound abatement foam the manufacturer confirmed there was no evidence of sound abatement foam degradation.Section a1, d9, g3, h6 have been updated/corrected.
 
Additional Manufacturer Narrative
In the previous report, section b5 was not updated, the correct b5 should be- the patient has alleged headaches, sore throat, dizziness, lightheaded, shortness of breath, nasal soreness, respiratory issues, inflammation and chest pain.There was no report of serious or permanent patient harm or injury.In this report, section h6 has been updated/corrected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DREAMSTATION CPAP PRO
Common Device Name
VENTILATOR, NON-CONTINUOUS (RESPIRATOR)
Manufacturer (Section D)
RESPIRONICS INC
1001 murry ridge lane
murrysville PA 15568
Manufacturer (Section G)
PHILIPS RESPIRONICS
6501 living place
pittsburgh PA 15206
Manufacturer Contact
rodney mell
1001 murry ridge lane
murrysville, PA 15668
7249003460
MDR Report Key12159581
Report Number2518422-2021-02150
Device Sequence Number14417384
Product Code BZD
UDI-Device Identifier00606959034501
UDI-Public00606959034501
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K131982
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Consumer
Initial Reporter Occupation Non-Healthcare Professional
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 03/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Model NumberCAX400H12C
Device Catalogue NumberCAX400H12C
Was Device Available for Evaluation? Device Returned to Manufacturer
Initial Date Received by Manufacturer 07/02/2021
Supplement Date Received by Manufacturer08/16/2021
03/20/2023
03/24/2023
Initial Report FDA Received Date07/13/2021
Supplement Report FDA Received Date09/09/2021
03/22/2023
03/23/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/19/2017
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
RES 88058
Patient Sequence Number1
Patient SexUnknown
-
-